Chromocell announces formal launch of eye pain treatment program and hiring of dr. simon chandler

Freehold, n.j., march 21, 2024 (globe newswire) -- chromocell therapeutics corp. (“chromocell”, or the “company”), (nyse american: chro), a pioneer in the development of non-opioid pain treatment therapeutics, today announced that it has formally launched its eye pain treatment program with the hiring of dr. simon chandler.
CHRO Ratings Summary
CHRO Quant Ranking